Nancy Lurker

Nancy Sue Lurker is Director at Altasciences Co., Inc. since 2021.
Independent Director at Alkermes Plc starting 2024.
Independent Director at Collegium Pharmaceutical, Inc. starting 2025.
Director at NSF International (Michigan) starting 2024.
Formerly President, Chief Executive Officer & Director at Interpace Biosciences, Inc. from 2011 to 2015.
President & Chief Executive Officer at ImpactRx, Inc. from 2003 to 2006.
President, Chief Executive Officer & Director at Pdi, Inc. (United States) from 2008 to 2015.
Chief Executive Officer & Director at EyePoint, Inc. in 2023.
Chairman at X4 Pharmaceuticals, Inc. from 2016 to 2018.
Senior Director-Worldwide Cardiovascular Franchise at Bristol Myers Squibb Co. in 1998.
Director at Elan Corp.
Plc from 2005 to 2006.
Independent Director at Auxilium Pharmaceuticals LLC from 2011 to 2015.
Director at Elan Pharmaceuticals LLC in 2006.
Independent Director at Aquestive Therapeutics, Inc. from 2018 to 2022.
Independent Director at Keenova Therapeutics Plc from 2013 to 2016.
Director at ConjuChem Biotechnologies, Inc. in 2006.
Director at Cancer Treatment Centers of America, Inc. from 2016 to 2020.
Vice President-Global Primary Care Products Group at Pharmacia Corp.
in 2003.
Chief Marketing Officer & Senior Vice President at Novartis Pharmaceuticals Corp.
from 2006 to 2007.
Vice President-Business Development at National Physicians Corp.
Education includes undergraduate degree from Seattle Pacific University and MBA from the University of Evansville.